Selank is a synthetic peptide derived from tuftsin, a naturally occurring immunomodulatory peptide known for its role in immune regulation and neuroprotection (Kolomin et al.). Originally developed by Russian researchers at the Institute of Molecular Genetics, Selank was designed as a potential alternative to traditional anxiolytic medications that could provide stress relief and cognitive benefits without the sedative effects associated with benzodiazepines (Volkova et al.).
One of Selank’s defining characteristics is its dual function as both an anxiolytic and a cognitive enhancer, making it a subject of interest in research on stress resilience, cognitive performance, and neurodegenerative conditions. Unlike pharmaceutical anti-anxiety drugs, which often lead to drowsiness, dependency, and withdrawal symptoms, Selank has been shown in studies to promote relaxation and mental clarity without impairing focus or cognitive function (Kolomin et al.).
Additionally, Selank has been explored for its role in modulating neurotransmitters like GABA and serotonin, which are crucial in mood regulation and emotional stability (Volkova et al.). Researchers have also investigated its potential neuroprotective and immunomodulatory properties, suggesting that Selank may have applications in inflammation-related neurological disorders and immune function regulation (Kolbaev et al.).
Because of these broad effects, Selank continues to be studied as a promising research candidate for anxiety, cognitive decline, neuroprotection, and stress-related disorders.
